Hankey, Graeme J., Hackett, Maree L., Lung, Thomas, Carter, Gregory, Murray, Veronica, Lundström, Eric, Anderson, Craig S., Herbert, Robert, Carter, Gregory, Donnan, Geoffrey A., Nguyen, Huy-Thang, Gommans, John, Yi, Qilong, Almeida, Osvaldo P., Li, Qiang, Bompoint, S, Barrett, S, Claxton, A, O'Dea, J, Tang, M, Williams, C, Peterson, S, Drummond, C, Hong, UH, Flicker, Leon, Le, LTM, Ngo, TTB, Mai, YB, Han, HT, Truong, NQ, Nguyen, HT, Ngo, HT, Nguyen, TB, Ha, OTK, Nguyen, TLH, Mead, Gillian E., Lindley, RI, New, P, Lee, A, Tran, TT, Le, LTTM, Kieu, TLV, Nguyen, SV, Nguyen, TAD, Dang, TN, Phan, HTT, Dennis, Martin S., Vo, LTN, Nguyen, MH, Dang, HC, Tran, HT, Dam, LTC, Ngo, TTK, Pham, TNT, Pham, BN, Dao, NTT, Nguyen, HTB, Etherton-Beer, Christopher, Le, LTC, Do, CM, Huynh, HQ, Tran, GTK, Le, OT, Tran, LTK, Duong, CD, Kieu, DV, Le, N, Nguyen, HN, Ford, Andrew H., Le, BV, Nguyen, LT, Nguyen, LV, Dinh, TQ, Vo, TV, Bui, TN, Hoang, UTT, Nguyen, HTB, Nguyen, HTT, Lam, NT, Billot, Laurent, Le, KK, Trinh, PT, Huynh, HQ, Nguyen, TTT, Lu, HN, Pham, TH, Nguyen, SH, Le, NH, Nguyen, GT, Doan, BT, Jan, Stephen, Pham, SP, Luong, DH, Mai, HV, Tran, TV, Do, PT, Le, HT, Nguyen, CV, Nguyen, PD, Mai, TD, Dao, PV. The Lancet Publishing Group; 2020. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.

Yassi, Nawaf, Zhao, Henry, Jeng, Jiann-Shing, Choi, Philip M. C., Duc, Phuc Dang, Brown, Helen, Ranta, Annemarei, Spratt, Neil, Cloud, Geoffrey C., Wang, Hao-Kuang, Grimley, Rohan, Mahawish, Karim, Churilov, Leonid, Cho, Der-Yang, Shah, D, Nguyen, TMP, Sharma, G, Yogendrakumar, V, Yan, B, Harrison, EL, Devlin, M, Cordato, D, Martinez-Majander, N, Wu, Teddy Y., Strbian, D, Thijs, V, Sanders, LM, Anderson, D, Parsons, MW, Campbell, BCV, Donnan, GA, Davis, SM, Ma, Henry, Nguyen, Huy-Thang, Cheung, Andrew, Meretoja, Atte, Mai, Duy Ton, Kleinig, Timothy. The Lancet Publishing Group; 2024. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.